Document is current

Article History

Received: 7 November 2024

Accepted: 22 July 2025

First Online: 14 August 2025

Declarations

:

: The study protocol was reviewed by the institutional review board of the Ministry of Health, Vector Control Division Research and Ethics Committee (Reference No. VCDREC106) and approved by the Uganda National Council of Science and Technology (Reference No. UNCST HS 118). The study was conducted with guidance from the district health officials, including the selection and training of the village health teams that were involved in the mobilization and recruitment of the school aged children into the study. The objectives, potential risks and benefits of the study were explained to the parents/guardians who signed informed consent and later explained to the school age children in English and Alur dialect who provided assent for participation into the study. Written formal consent from parents and written assent from the children were obtained. If a child was observed to have S. mansoni eggs in their stool, they were offered free treatment, which consisted of praziquantel at a dosage of 40 mg/kg administered by trained Ministry of Health personnel, assisted by the district health worker.

: Not applicable.

: The authors declare no competing interests.